Literature DB >> 6875378

Effects of human brain cell culture conditions on [14C]glucosamine radioactivity incorporation into gangliosides.

V A Liepkalns, C Icard-Liepkalns, A J Yates, S Mattison, R E Stephens.   

Abstract

Human glioma cells (12-18) and fetal neural cells (CH II) in culture were exposed for 20 hr to [14C]glucosamine to determine the level and distribution of radiolabel incorporated into gangliosides. Cells of identical passage levels at two stages of growth, preconfluent and confluent, were preincubated for 0 to 60 hr in serum-free medium (SFM). Both higher cell densities and longer incubations in SFM caused a change in the amounts and patterns of radiolabeled gangliosides. Preincubation for 60 hr in SFM caused an increase (P less than 0.05) in the percent of total recovered ganglioside radiolabel in GM1 of CH II cells, from 10.5 to 16.7% in preconfluent cells and from 14.1 to 31.9% in confluent cells. Conversely, the proportion of radiolabel in GM3 and GM2 decreased with longer preincubations in SFM. A similar preincubation of glioma cells caused an increase in the proportion of label into GD1a of both preconfluent and confluent cells (P less than 0.02) from 4 to 11% of the total ganglioside radioactivity. Higher cell densities also resulted in consistently higher percent (of total ganglioside) incorporation into GD1a of 12-18 cells (P less than 0.05) and GM1 of CH II (P less than 0.01). These results show that there is a shift in the incorporation of precursor label into more complex gangliosides under conditions associated with the arrest of cell division. These phenomena may represent a regulatory response of the ganglioside biosynthetic apparatus to changes in extracellular environment and cell contact.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6875378

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  3 in total

1.  In vivo growth conditions suppress the expression of ganglioside GM2 and favour that of lacto series gangliosides in the human glioma D-54MG cell line.

Authors:  P Fredman; C J Wikstrand; J E Månsson; G Reifenberger; S H Bigner; A Rasheed; L Svennerholm; D D Bigner
Journal:  Glycoconj J       Date:  1996-06       Impact factor: 2.916

2.  Brain glycogen serves as a critical glucosamine cache required for protein glycosylation.

Authors:  Ramon C Sun; Lyndsay E A Young; Ronald C Bruntz; Kia H Markussen; Zhengqiu Zhou; Lindsey R Conroy; Tara R Hawkinson; Harrison A Clarke; Alexandra E Stanback; Jessica K A Macedo; Shane Emanuelle; M Kathryn Brewer; Alberto L Rondon; Annette Mestas; William C Sanders; Krishna K Mahalingan; Buyun Tang; Vimbai M Chikwana; Dyann M Segvich; Christopher J Contreras; Elizabeth J Allenger; Christine F Brainson; Lance A Johnson; Richard E Taylor; Dustin D Armstrong; Robert Shaffer; Charles J Waechter; Craig W Vander Kooi; Anna A DePaoli-Roach; Peter J Roach; Thomas D Hurley; Richard R Drake; Matthew S Gentry
Journal:  Cell Metab       Date:  2021-05-26       Impact factor: 31.373

3.  Chemical reporter for visualizing metabolic cross-talk between carbohydrate metabolism and protein modification.

Authors:  Balyn W Zaro; Kelly N Chuh; Matthew R Pratt
Journal:  ACS Chem Biol       Date:  2014-07-29       Impact factor: 5.100

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.